The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City

Prediabetes Clinical Trial

Official title:

The Study for the Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City- Comparison of Agreement for Prevalence of Metabolic Syndrome Among the WHO, NCEP ATP III and Taiwan Definitions

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00308672
• Other study ID #: NSC94-2314-B-039-024
• Status: Recruiting
• Phase: N/A
• First received: March 29, 2006
• Last updated: March 29, 2006
• Start date: August 2005
• Est. completion date: July 2006

Study information

• Verified date: March 2006
• Source: China Medical University Hospital
• Contact: Li C Ing, MS.
• Phone: 886-4-22052121
• Email: a6446[@]www.cmuh.org.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

The secondary objective is to evaluate the agreement between these criteria and the prevalence of concordant and discordant according to different criteria.

Description:

Up to now, there has been to uniform case definition for the metabolic syndrome. The World Health Organization and the Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III), and Bureau of Health Promotion, Taiwan proposed different criteria for the metabolic syndrome. Therefore, the secondary objective is to evaluate the agreement between these criteria and the prevalence of concordant and discordant according to different criteria. Three thousand persons will be randomly selected from resident of Taichung City. All the participants will fulfill a structured questionnaire. Blood pressure, anthropometric variables are measured. Biochemical markers are analyzed by a biochemical autoanalyzer. Kappa will be used to estimate the agreement between different criteria.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: July 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

Residents aged 40 and over of Taichung City, Taiwan in October, 2004.

Exclusion Criteria:

Study Design

Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Metabolic Syndrome X
• Prediabetes

Locations

Country	Name	City	State
Taiwan	China Medical University Hospital	Taichung city

Sponsors (2)

Lead Sponsor	Collaborator
China Medical University Hospital	National Science Council, Taiwan

Country where clinical trial is conducted

Taiwan,